Načítá se...
Design of Safe Nanotherapeutics for the Excretion of Excess Systemic Toxic Iron
[Image: see text] Chronic transfusion of red blood cells (RBCs) to patients with β-thalassemia, sickle cell disease, and other acquired anemic disorders generates significant amounts of bioactive iron deposits in the body. The inactivation and excretion of redox active iron(III) from the blood pool...
Uloženo v:
| Vydáno v: | ACS Cent Sci |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Chemical Society
2019
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535967/ https://ncbi.nlm.nih.gov/pubmed/31139728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acscentsci.9b00284 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|